HEALY JAMES

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$76.37M
Insider Sells Quantity
14
Insider Sells Sum
$152.38M

Insider Activity of HEALY JAMES

The largest purchase of all time was on 2018-09-21 and amounted to 1000000 shares of Y-mAbs Therapeutics, Inc. for $16M.

The largest sale of all time was on 2012-04-03 and amounted to 3471300 shares of Amarin Corporation plc for $38.12M.

Biography of HEALY JAMES

No biography is available at this moment.

2023-12-13SaleNatera, Inc.
NTRA
director
644,000
0.727%
$58.75$37.84M+78.7%
2022-11-16SaleNatera, Inc.
NTRA
director
2,400
0.0025%
$37.71$90,498+32.18%
2021-09-29SaleCoherus BioSciences, Inc.
CHRS
director
286,076
0.3546%
$16.12$4.61M-26.09%
2021-09-28SaleCoherus BioSciences, Inc.
CHRS
director
48,329
0.0622%
$17.17$829,809-27.59%
2021-09-27SaleCoherus BioSciences, Inc.
CHRS
director
100,150
0.1287%
$18.06$1.81M-30.86%
2021-07-22PurchaseNatera, Inc.
NTRA
director
2,400
0.0025%
$113.00$271,200-39.35%
2021-02-09PurchaseBolt Biotherapeutics, Inc.
BOLT
director
450,000
36.7082%
$20.00$9M-58.82%
2019-10-30PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
180,000
0.4411%
$28.00$5.04M+22.3%
2019-07-02SaleCoherus BioSciences, Inc.
CHRS
director
320,000
0.451%
$22.61$7.24M-19.69%
2019-06-28SaleCoherus BioSciences, Inc.
CHRS
director
400,000
0.5744%
$22.05$8.82M-16.33%
2019-06-20SaleCoherus BioSciences, Inc.
CHRS
director
634,260
0.9007%
$21.37$13.55M-14.29%
2019-05-22SaleCoherus BioSciences, Inc.
CHRS
director
515,740
0.747%
$20.69$10.67M-9.48%
2018-09-21PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
1M
2.4393%
$16.00$16M-5.15%
2018-08-29SaleCoherus BioSciences, Inc.
CHRS
director
50,000
0.075%
$20.50$1.02M-26.35%
2018-05-30PurchaseIterum Therapeutics plc
ITRM
1M
15.1004%
$13.00$13M-40.58%
2016-03-11PurchasePDS Biotechnology Corporation
PDSB
director
541,343
1.8335%
$7.30$3.95M+31.28%
2015-10-06PurchasePDS Biotechnology Corporation
PDSB
director
900,000
2.0157%
$11.00$9.9M-45.67%
2015-07-08PurchaseNatera, Inc.
NTRA
director
175,000
0.3264%
$18.00$3.15M-52.68%
2015-07-02PurchaseNatera, Inc.
NTRA
director
200,000
0.4464%
$22.81$4.56M-43.64%
2014-11-12PurchaseCoherus BioSciences, Inc.
CHRS
director
851,852
9.7417%
$13.50$11.5M+82.59%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.